Fairport, NY, United States of America

Brian R Rohrs

This inventor holds 1 USPTO granted patent. Top assignee: Bausch Health Ireland Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian R Rohrs. Retrieved from https://idiyas.com/inventor/brian-r-rohrs-0uhxsqof

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Brian R Rohrs

Introduction

Brian R Rohrs is an accomplished inventor based in Fairport, NY (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the targeted delivery of medications. His work focuses on improving treatment methods for gastrointestinal disorders.

Latest Patents

Brian R Rohrs holds 1 patent for his invention titled "Targeted release rifaximin compositions." This patent provides gastrointestinal-specific rifaximin release compositions that can be formulated for targeted delivery to various portions of the GI tract. The invention also includes methods for treating diseases and disorders using these compositions.

Career Highlights

Rohrs is currently employed at Bausch Health Ireland Limited, where he continues to innovate in the pharmaceutical industry. His expertise in drug formulation and delivery systems has positioned him as a valuable asset to his company.

Collaborations

Throughout his career, Brian has collaborated with notable colleagues, including Ezra R Lowe and Daniel J Stein. These partnerships have contributed to the advancement of his research and the development of effective treatment solutions.

Conclusion

Brian R Rohrs exemplifies the spirit of innovation in the pharmaceutical field through his targeted delivery systems for medications. His contributions are paving the way for improved treatment options for patients with gastrointestinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…